High-performance liquid chromatographic analysis of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378

Research Communications in Molecular Pathology and Pharmacology

Volumn 109, Issue 3-4, 2001, Pages 249-256

  Lee, M H ^a   Kim, H J ^a   Kim, S H ^a   Kim, S O ^a   Lee, D H ^a   Lim, H ^a   Yoo, S E ^a   Lee, M G ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

KR 31378; N'' CYANO N (6 AMINO 3,4 DIHYDRO 3 HYDROXY 2 METHYL 2 DIMETHOXYMETHYL 2H BENZOPYRAN 4 YL) N' BENZYLGUANIDINE; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIA; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; OPTICAL ROTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TISSUE HOMOGENATE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GUANIDINES; HUMANS; INDICATORS AND REAGENTS; NEUROPROTECTIVE AGENTS; PYRANS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; REPERFUSION INJURY; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION;

EID: 0035190624     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of methotrexate and its metabolites in plasma, saliva and urine
2. Determination of a new proton pump inhibitor, YH1885, in human plasma and urine by high-performance liquid chromatography
3. Determination of azosemide and its metabolite in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography
4. Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats